Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. has released its financial results for the nine-month period ending on September 30, 2024.

The company's sales for this period amounted to CNY 968.59 million, which is lower than the CNY 1,044.24 million recorded in the same period last year. Similarly, the revenue figures also decreased to CNY 968.59 million compared to CNY 1,044.24 million in the previous year.

Despite the decline in sales and revenue, Tonghua Golden-Horse achieved a net income of CNY 23.92 million, showing an increase from the CNY 15.55 million reported a year ago. The basic and diluted earnings per share from continuing operations also improved, rising to CNY 0.0248 from CNY 0.0161 in the prior year, indicating enhanced profitability on a per-share basis.